Evoke Pharma (EVOK) Retained Earnings (2020 - 2025)
Historic Retained Earnings for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to -$132.8 million.
- Evoke Pharma's Retained Earnings fell 409.57% to -$132.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$132.8 million, marking a year-over-year decrease of 409.57%. This contributed to the annual value of -$128.8 million for FY2024, which is 433.59% down from last year.
- According to the latest figures from Q3 2025, Evoke Pharma's Retained Earnings is -$132.8 million, which was down 409.57% from -$131.7 million recorded in Q2 2025.
- Evoke Pharma's Retained Earnings' 5-year high stood at -$101.5 million during Q1 2021, with a 5-year trough of -$132.8 million in Q3 2025.
- For the 5-year period, Evoke Pharma's Retained Earnings averaged around -$118.6 million, with its median value being -$119.8 million (2023).
- In the last 5 years, Evoke Pharma's Retained Earnings tumbled by 1596.18% in 2021 and then crashed by 406.22% in 2025.
- Over the past 5 years, Evoke Pharma's Retained Earnings (Quarter) stood at -$107.4 million in 2021, then fell by 7.66% to -$115.6 million in 2022, then dropped by 6.74% to -$123.4 million in 2023, then fell by 4.34% to -$128.8 million in 2024, then dropped by 3.13% to -$132.8 million in 2025.
- Its Retained Earnings was -$132.8 million in Q3 2025, compared to -$131.7 million in Q2 2025 and -$130.1 million in Q1 2025.